Cocrystal Pharma's Participation in the Noble Capital Markets C-Suite Interview Series is Now Available OnlineGlobeNewsWire • 06/09/21
Cocrystal stock pulls back sharply after stock offering priced to the public at a deep discountMarket Watch • 05/05/21
Cocrystal stock doubles on massive volume a day after progress announced on coronavirus drug candidatesMarket Watch • 05/04/21
Cocrystal Pharma Stock Gains After Laying Out Plans To Launch Another COVID-19 Antiviral CandidateBenzinga • 05/03/21
Cocrystal Pharma Reports 2020 Financial Results, Provides Business Update Including Antiviral Program MilestonesGlobeNewsWire • 03/17/21
Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference [UPDATED]GlobeNewsWire • 03/02/21
Cocrystal Pharma Presentation at the reimagine Health Research Symposium Features Overview of Platform Technology and Four Antiviral Case StudiesGlobeNewsWire • 01/21/21
Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration AgreementGlobeNewsWire • 01/19/21
Cocrystal Pharma to Present at Virtual NobleCon17 Conference on January 19, 2021GlobeNewsWire • 01/12/21
Cocrystal Pharma Selects Lead Compound for Further Development Against CoronavirusesGlobeNewsWire • 12/22/20